Erratum: Subjects no more: What happens when trial participants realize they hold the power? (BMJ (Online) (2014) 348(g368) DOI: 10.1136/bmj.g368);Subjects no more: What happens when trial participants realize they hold the power?

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Wicks, Paul ^a   Vaughan, Timothy ^a   Heywood, James ^a  

^a PatientsLikeMe   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; CLINICAL PROTOCOL; CLINICAL RESEARCH; ELECTRONIC MEDICAL RECORD; HEALTH STATUS; HUMAN; PATIENT ADVOCACY; PATIENT ATTITUDE; PATIENT AUTONOMY; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRIORITY JOURNAL; RESEARCH ETHICS; RESEARCH SUBJECT;

CLINICAL TRIALS AS TOPIC; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; HUMANS; MODELS, STATISTICAL; PATIENT SELECTION; SAMPLE SIZE;

EID: 84893333048     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g3383     Document Type: Erratum

References (19)

1. Partridge AH, Winer EP. Sharing study results with trial participants: time for action. J Clin Oncol 2009;27:838-9.
2. Cox K, Moghaddam N, Bird L, Elkan R. Feedback of trial results to participants: a survey of clinicians' and patients' attitudes and experiences. Eur J Oncol Nurs 2011;15:124-9.
3. Science Direct. Pay per view. http://info.sciencedirect.com/ sciencedirect/buying/individual-article-purchase-options/ppv.
4. Workman TA. Engaging patients in information sharing and data collection: the role of patient-powered registries and research networks. US Agency for Healthcare Research and Quality, 2013.
5. Frost JH, Massagli MP, Wicks P, Heywood J. How the social web supports patient experimentation with a new therapy: The demand for patient-controlled and patient-centered informatics. AMIA Annu Symp Proc 2008:217-21.
6. Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML, et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2008;105:2052-7.
7. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999;169:13-21.
8. O'Connor D. The apomediated world: regulating research when social media has changed research. J Law Med Ethics 2013;41:470-83.
9. Vayena E, Tasioulas J. Adapting standards: ethical oversight of participant-led health research. PLOS Med 2013;10:e1001402.
10. Wicks P, Massagli M, Frost J, Macedo H, Felzer K, Heywood J. A patient-led trial of lithium in ALS using the internet. Amyotroph Lateral Scler 2008;9:S59.
11. Wicks P, Vaughan TE, Massagli MP, Heywood J. Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm. Nat Biotechnol 2011;29:411-4.
12. Armon C. Is the lithium-for-ALS genie back in the bottle? Not quite. Neurology 2010;75:586-7.
13. Dokser Marcus A. Frustrated ALS patients concoct their own drug. Wall St Journal 2012 Apr 15. http://online.wsj.com/news/articles/ SB10001424052702304818404577345953943484054.
14. Heywood J. Waiting for P<0.05. Figshare 2012. http://dx.doi.org/10. 6084/m9.figshare. 96802
15. Castrillo-Viguera C, Grasso DL, Simpson E, Shefner J, Cudkowicz ME. Clinical significance in the change of decline in ALSFRS-R. Amyotroph Lateral Scler 2010;11:178-80.
16. Cudkowicz ME, van den Berg LH, Shefner JM, Mitsoumuto H, Mora JS, Ludolph A, et al. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial. Lancet Neurol 2013;12:1059-67.
17. ALSUntangled Group. ALSUntangled No 19: Sodium chlorite. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:236-8.
18. Wicks P, Heywood B, Heywood J. Online platform to accelerate patient involvement in open instrument development. Qual Life Res 2013;22:1-137.
19. Gnanasakthy A, Mordin M, Clark M, DeMuhro C, Fehnel S, Copley-Merriman C. A review of patient-reported outcome labels in the United States: 2006 to 2010. Value Health 2012;15:437-42.